enVVeno Medical Corporation
NVNO
Last
$8.70
Day
+6.4%
1y
-75.6%
5y
-97.7%
52w
-76.8%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-10-3020d
EMA 21
8.81
EMA 50
9.59
EMA 200
18.61
20d high
-20.8%
5y high
-97.8%
5y range
0th
Positions held
Your positionsNVNO isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-12
Hold
avoid
Signal
Sell
Target
$9.27
Stop
$7.26
Stop distance
16.6%
Target vs last
+6.5%
Fundamentals
| Market cap | $5.68M | Enterprise value | -$15.40M | Trailing P/E | — | Forward P/E | -1.31 |
| PEG | — | Price / book | 0.27 | Beta | 1.29 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -58.5% | ROA | -36.7% | Debt / equity | 0.02 |
| Current ratio | 11.70 | Free cash flow | -$9.59M | Analyst recommendation | none | Mean target | $30.00 |
| 52w high | $30.80 | 52w low | $7.01 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$3.6M | -$3.8M | -$3.7M | -$4.5M | -$6.7M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$3.8M | -$4.1M | -$4.0M | -$4.9M | -$7.0M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — |
| Net income | -$19.5M | -$21.8M | -$23.5M | -$24.7M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$20.9M | -$23.8M | -$25.2M | -$24.9M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsNVNO · daily-10.2% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin